# France Veterinary Infusion Pumps Market > France Veterinary Infusion Pumps Market Research Report By Type (Syringe Infusion Pump, Large-Volume Infusion Pump) and By End-user (Veterinary Hospitals, Veterinary Clinics, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.07% - **2024:** $ 4.05 Million - **2025:** $ 4.21 Million - **2035:** $ 6.28 Million - **Key Players:** B. Braun Melsungen AG (DE), Vetland Medical (US), Smiths Medical (US), Draegerwerk AG (DE), Medtronic (IE), Heska Corporation (US), Zoetis Inc. (US), Vetoquinol SA (FR) **Report ID:** MRFR/HC/52381-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/france-veterinary-infusion-pumps-market-54144 --- ## Market Summary ## **France Veterinary Infusion Pumps Market Overview** As per MRFR analysis, the France Veterinary Infusion Pumps Market Size was estimated at 3.12 (USD Million) in 2023. The market is expected to grow from 3.24 (USD Million) in 2024 to 5.2 (USD Million) by 2035. The France Veterinary Infusion Pumps Market CAGR (growth rate) is expected to be around 4.395% during the forecast period (2025 - 2035). ### **Key France Veterinary Infusion Pumps Market Trends Highlighted** The market for veterinary infusion pumps in France is being shaped by a number of noteworthy trends. First, France's burgeoning pet ownership culture is driving a greater focus on modern veterinarian treatment. More veterinary clinics are using advanced infusion pumps to guarantee accurate medicine delivery as a result of the growing demand for specialist pet care. The French government's efforts to improve animal health standards, which incentivize vets to purchase cutting-edge medical equipment, further reinforce this trend. There are several opportunities in this sector, especially as telemedicine becomes more popular in the veterinary industry. In order to improve patient surveillance and management from a distance, animal healthcare providers are investigating remote monitoring systems in conjunction with infusion pumps. This is particularly advantageous in France's rural areas, where veterinary care may be harder to come by. Furthermore, there is a chance to create educational initiatives targeted at veterinarians that encourage the adoption of cutting-edge infusion technology as knowledge of developments in veterinary medicine grows. Digital technology integration into veterinary operations has become a popular trend in recent years. Many veterinary clinics in France are starting to implement software solutions to improve the performance of infusion pumps and provide better patient care and monitoring. This pattern is indicative of a broader movement in the healthcare industry to use technology that improves treatment accuracy and efficiency. All things considered, these major trends, opportunities, and a general dedication to raising the bar for veterinary care in France are what are propelling the market for veterinary infusion pumps to keep expanding. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **France Veterinary Infusion Pumps Market Drivers** #### **Increasing Pet Ownership and Spending on Animal Health** In France, the pet ownership rate has seen a significant rise, with approximately 63 million pets reported in recent statistics. The French government and veterinary associations have emphasized the importance of animal health, resulting in increased expenditure on veterinary care. According to the French Ministry of Agriculture, pet owners now spend over 2 billion euros annually on veterinary services, which includes advanced medical equipment like infusion pumps. This increased investment in pet healthcare directly drives the demand within the France Veterinary Infusion Pumps Market, as veterinarians seek to provide high-quality care for their patients, reflecting a growing trend in responsible pet ownership and the willingness to invest in health services. #### **Technological Advancements in Veterinary Medicine** Innovations in veterinary technologies, including the development of advanced infusion pumps, have significantly impacted the France Veterinary Infusion Pumps Market. With the emergence of smart infusion devices offering enhanced safety features and better dosage accuracy, the demand for such devices has surged. Notably, organizations like the French National Veterinary School are actively involved in Research and Development to evaluate and adopt new technologies into practice. The introduction of user-friendly, programmable infusion pumps has resulted in improved efficiency in veterinary services, ultimately contributing to the growth of the market and addressing the increasing complexity of veterinary cases. #### **Rising Incidence of Chronic Diseases in Animals** The prevalence of chronic diseases such as diabetes and kidney failure in domesticated animals has been on the rise in France, prompting a greater need for specialized veterinary care. Studies suggest that there has been an estimated 15% increase in chronic disease cases among pets over the past decade, according to the French Veterinary Association. This trend necessitates the use of infusion pumps to manage fluid therapy and medication delivery. As veterinarians adapt to these rising healthcare needs, the demand for reliable veterinary infusion pumps within the France Veterinary Infusion Pumps Market is expected to expand, allowing for comprehensive treatment options for affected animals. ## **France Veterinary Infusion Pumps Market Segment Insights** ### **Veterinary Infusion Pumps Market Type Insights** The France Veterinary Infusion Pumps Market is characterized by its diverse range of Type segments, with key classifications including Syringe Infusion Pumps and Large-Volume Infusion Pumps. Syringe Infusion Pumps are integral to delivering precise and controlled dosages in veterinary settings, allowing for meticulous medication administration tailored to individual animal needs. This precision ensures enhanced patient care and minimizes the risks associated with over or under-dosing. Meanwhile, Large-Volume Infusion Pumps cater to procedures requiring substantial fluid administration, such as critical care situations where hydration and continuous medicine delivery are vital. As veterinary procedures become more advanced, the demand for these devices rises in France, driven by increasing awareness regarding pet health and the necessity for effective treatment protocols. Additionally, innovations in technology are steering the growth of these segments, with manufacturers focusing on user-friendly interfaces and automated systems to improve operational efficiency in veterinary practices. The importance of these Type segments is underscored by the rising trends surrounding animal welfare, where quick access to reliable infusion methods is paramount. Furthermore, the ongoing developments in veterinary medicine and the growing number of specialized animal healthcare facilities underline the significance of these infusion pumps in ensuring optimal treatment outcomes. Collectively, the France Veterinary Infusion Pumps Market segmentation reflects a critical intersection of technological advancement and evolving veterinary clinical practices, serving as a foundation for improved health management in the animal care landscape. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Veterinary Infusion Pumps Market End-user Insights** The France Veterinary Infusion Pumps Market showcases significant insights within the End-user segment, which includes Veterinary Hospitals, Veterinary Clinics, and Others. Veterinary Hospitals play a crucial role in the market, often being equipped with advanced infusion systems to manage critical cases effectively. These facilities usually possess the infrastructure and expertise to handle major medical procedures and emergencies, leading to an increased demand for sophisticated infusion pumps. In comparison, Veterinary Clinics focus on providing preventive and routine medical care, where the need for infusion pumps is driven by various treatments such as fluid therapy and medication administration, thus contributing substantially to the overall market dynamics. The "Others" category encompasses various alternative veterinary service providers, including mobile clinics and specialized treatment centers, which are emerging as important players in the infusion landscape. As the demand for better veterinary care rises, these segments are increasingly adopting high-quality infusion systems. Overall, the growing awareness regarding animal health and advancements in veterinary technologies continues to propel the market forward, presenting opportunities for innovative developments within the France Veterinary Infusion Pumps Market. ## **France Veterinary Infusion Pumps Market Key Players and Competitive Insights** The competitive landscape of the France Veterinary Infusion Pumps Market is characterized by a diverse range of players, each striving to establish their footprint in a sector that is witnessing significant growth. As the demand for advanced veterinary care increases, companies are innovating to offer sophisticated infusion solutions tailored for animals. This market is driven by technology advancements and rising awareness among pet owners regarding health management in animals. Companies are increasingly focusing on enhancing product quality, user-friendliness, and intelligence in their infusion pumps to effectively meet clinical needs. In the context of the France Veterinary Infusion Pumps Market, VetaPharma stands out for its strong commitment to delivering high-quality veterinary products. The company has established a reputable presence in the French market, driven by its specialized focus on veterinary needs. VetaPharma has leveraged its existing relationships with veterinary practices and clinics to ensure the adoption of its infusion pumps. The company's strengths lie in its dedication to research and development, which allows it to continuously improve its offerings and address the evolving requirements of veterinary professionals. This alignment with customer needs and a proactive approach to support bolster VetaPharma's competitive edge in the market. MediLynx further enriches the competitive fabric of the France Veterinary Infusion Pumps Market with its portfolio of innovative products and services tailored for veterinary applications. The company is known for its specialized infusion pumps designed for various animal types, ensuring effective treatment solutions. MediLynx has strategically positioned itself in the market by emphasizing collaboration with veterinary hospitals and clinics, thereby enhancing its visibility and market penetration. The strengths of MediLynx include its focus on technology integration, offering user-friendly interfaces, and reliable product performance. Recent mergers and acquisitions have enabled the company to expand its technological capabilities and product range in the French veterinary sector, affirming its commitment to quality and innovation. By consistently addressing market demands, MediLynx maintains a solid position as a key player in the landscape of veterinary infusion solutions in France. ### **Key Companies in the France Veterinary Infusion Pumps Market Include** - VetaPharma - MediLynx - Henry Schein - Abbott Laboratories - Irvine Scientific - Zoetis - Smiths Medical - Heska Corporation - [Medtronic](https://www.medtronic.com/animal-health/en-us/index.html) - Merit Medical Systems - Vygon - B. Braun Melsungen AG - Dechra Pharmaceuticals - Baxter International - Elastomer Solutions ### **France Veterinary Infusion Pumps Market Developments** In recent developments within the France Veterinary Infusion Pumps Market, there has been a notable increase in demand driven by the growing emphasis on animal healthcare and advanced treatment methods. Major players like MediLynx and Zoetis are focusing on enhancing their product offerings with innovative infusion technologies. Additionally, in October 2023, Smiths Medical announced a strategic partnership with Dechra Pharmaceuticals to enhance distribution channels in France, allowing for improved accessibility to veterinary infusion solutions. The competitive landscape is evolving, as companies such as Merit Medical Systems continue to invest in Research and Development to introduce more efficient infusion systems tailored for veterinary use. There have also been reports of increased market valuation for firms like Vygon and B. Braun Melsungen AG, indicating a robust growth trajectory that is expected to impact the sector positively. In the past two years, companies like Abbott Laboratories and Heska Corporation have expanded their presence in France, reinforcing their market positions through product diversification. The integration of advanced technologies and increased regulatory support in France is anticipated to further stimulate growth in the veterinary infusion segment, ensuring better outcomes for treatments in companion and farm animals alike. ### **France Veterinary Infusion Pumps Market Segmentation Insights** #### **Veterinary Infusion Pumps Market Type Outlook** - Syringe [Infusion Pump](../../../reports/infusion-pumps-market-1509) - Large-Volume Infusion Pump #### **Veterinary Infusion Pumps Market End-user Outlook** - Veterinary Hospitals - Veterinary Clinics - Others ## Market Drivers ### Rising Pet Ownership The veterinary infusion-pumps market in France is experiencing growth due to the increasing number of pet owners. As more households adopt pets, the demand for veterinary services, including infusion therapies, rises. In 2025, it is estimated that approximately 50% of French households own a pet, leading to a heightened need for advanced medical equipment. This trend is particularly evident in urban areas where pet ownership is more prevalent. The infusion-pumps market is likely to benefit from this demographic shift, as pet owners seek high-quality care for their animals. Consequently, veterinary clinics are investing in modern infusion technologies to meet the expectations of pet owners, thereby driving the market forward. ### Regulatory Developments The veterinary infusion-pumps market is also shaped by regulatory developments in France. The government has implemented stricter regulations regarding veterinary practices and the use of medical devices. The government has implemented stricter regulations regarding veterinary practices and the use of medical devices. These regulations aim to ensure the safety and efficacy of veterinary treatments, which in turn drives the demand for high-quality infusion-pumps. Compliance with these regulations often requires veterinary clinics to upgrade their equipment, leading to increased sales in the market. As the regulatory landscape continues to evolve, it is expected that veterinary practices will increasingly adopt advanced infusion technologies to meet compliance standards, thereby propelling market growth. ### Increased Focus on Animal Health The veterinary infusion-pumps market is benefiting from a growing emphasis on animal health and welfare in France. Pet owners are becoming more conscious of their animals' health needs, leading to increased spending on veterinary services. Pet owners are becoming more conscious of their animals' health needs, leading to increased spending on veterinary services. In 2025, the French pet care market is projected to reach €5 billion, with a substantial portion allocated to medical treatments. This heightened awareness is prompting veterinary clinics to invest in advanced infusion-pump technologies to provide better care. As a result, the market is likely to see a surge in demand for these devices, reflecting the changing attitudes towards animal healthcare and the importance of effective treatment options. ### Advancements in Veterinary Medicine The veterinary infusion-pumps market is significantly influenced by advancements in veterinary medicine. Innovations in treatment protocols and the development of new drugs necessitate the use of sophisticated infusion systems. In France, veterinary practices are increasingly adopting these technologies to enhance patient outcomes. The market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the need for precise drug delivery systems. As veterinarians become more aware of the benefits of infusion therapy, the demand for advanced infusion-pumps is expected to rise. This trend indicates a shift towards more specialized veterinary care, which is likely to further stimulate the market. ### Technological Integration in Veterinary Practices The integration of technology in veterinary practices is a key driver for the veterinary infusion-pumps market. With the rise of telemedicine and digital health records, veterinary clinics are increasingly adopting infusion-pump systems. With the rise of telemedicine and digital health records, veterinary clinics are increasingly adopting infusion-pump systems that can integrate with these technologies. This integration allows for better monitoring and management of patient care, enhancing treatment outcomes. In France, the trend towards digitalization in veterinary medicine is expected to grow, with a projected increase in the use of connected devices. As veterinary practices seek to improve efficiency and patient care, the demand for technologically advanced infusion-pumps is likely to rise, further stimulating market growth. ## Future Outlook The [Veterinary Infusion Pumps Market](https://www.marketresearchfuture.com/reports/veterinary-infusion-pumps-market-7417) in France is projected to grow at a 4.07% CAGR from 2025 to 2035, driven by technological advancements and increasing pet healthcare expenditures. **New opportunities:** - Development of portable infusion-pump systems for veterinary clinics Integration of IoT technology for real-time monitoring Expansion of subscription-based service models for maintenance and support By 2035, the market is expected to achieve robust growth, reflecting evolving veterinary care demands. ## Segment Insights ### By Type: Syringe Infusion Pump (Largest) vs. Large-Volume Infusion Pump (Fastest-Growing) In the France veterinary infusion-pumps market, the segment distribution reveals that Syringe Infusion Pumps hold a significant share, reflecting their widespread adoption in veterinary practices. These pumps are favored for their precision, which is critical in administering medications to animals, thus enhancing their popularity among veterinarians. Conversely, Large-Volume Infusion Pumps, while smaller in current market share, are gaining traction due to their capability to handle larger volumes, catering to a growing demand in various veterinary procedures. Growth trends in this segment are driven by advancements in technology and an increasing focus on animal welfare. The Syringe Infusion Pump remains dominant due to its established presence and reliability, while the Large-Volume Infusion Pump is emerging rapidly, supported by veterinary hospitals seeking efficiency in treatment delivery. The push for improved healthcare outcomes in animals further propels this growth, making both segments critical to the market's future. Syringe Infusion Pump (Dominant) vs. Large-Volume Infusion Pump (Emerging) Syringe Infusion Pumps are known for their ability to provide precise dosing, making them indispensable in the veterinary field. Their design facilitates careful administration of medications, crucial in critical care settings, thus maintaining a dominant position in the market. On the other hand, Large-Volume Infusion Pumps are considered emerging due to their growing adoption, particularly in larger veterinary settings that require efficient management of fluid therapy for multiple patients simultaneously. They enable a more streamlined workflow, allowing for increased patient throughput, which is becoming essential as veterinary practices expand to meet rising demands for care. ### By End-User: Veterinary Hospitals (Largest) vs. Veterinary Clinics (Fastest-Growing) In the France veterinary infusion-pumps market, the majority share is held by veterinary hospitals, which dominate due to their expansive resources and capability to handle complex cases involving infusion therapy. Veterinary clinics, while currently a smaller player, are rapidly gaining traction and are expected to increase their market presence significantly due to the rising number of small animal treatments and outpatient services offered by these clinics. The growth trends in this segment are driven by an increase in pet ownership and a growing awareness of advanced veterinary care options. As more clinics integrate modern veterinary infusion-pumps into their practices, they not only enhance their service offerings but also attract a broader client base. Additionally, advancements in infusion technology are prompting hospitals to adopt more sophisticated systems, further solidifying their role in this market. Veterinary Hospitals (Dominant) vs. Veterinary Clinics (Emerging) Veterinary hospitals are currently the dominant force in the France veterinary infusion-pumps market due to their ability to provide comprehensive care for complex pet health issues requiring detailed monitoring and advanced therapies. These facilities are usually well-equipped with state-of-the-art infusion-pump systems that can manage a variety of treatment protocols. On the other hand, veterinary clinics represent an emerging segment that is gradually transforming the market landscape. Many clinics are investing in newer technologies to meet the growing expectations of pet owners for high-quality care, leading to increased demand for infusion-pumps. This trend shows a shift towards more localized and accessible veterinary services, paving the way for innovations to cater to smaller facilities' needs while enhancing patient outcomes. ## Competitive Benchmarking The veterinary infusion-pumps market in France is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on enhancing patient care. Key players such as B. Braun Melsungen AG (DE), Medtronic (IE), and Vetoquinol SA (FR) are actively pursuing strategies that emphasize technological advancements and regional expansion. B. Braun Melsungen AG (DE) has positioned itself as a leader through its commitment to research and development, focusing on creating user-friendly and efficient infusion systems. Meanwhile, Medtronic (IE) is leveraging its extensive experience in medical technology to enhance its product offerings, particularly in the realm of digital health solutions, which are becoming increasingly relevant in veterinary practices. Vetoquinol SA (FR), a domestic player, is concentrating on local market needs, tailoring its products to meet the specific demands of French veterinarians, thereby strengthening its competitive edge.The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in the context of fluctuating global supply chains. The collective influence of these key players is significant, as they not only drive innovation but also set industry standards that smaller companies may strive to meet. In October B. Braun Melsungen AG (DE) announced the launch of a new line of veterinary infusion pumps designed specifically for small animal practices. This strategic move is likely to enhance their market presence by addressing the unique needs of this segment, which has been underserved in the past. The introduction of these specialized products may also reflect a broader trend towards customization in veterinary care, allowing practitioners to provide more tailored treatments. In September Medtronic (IE) expanded its partnership with a leading veterinary hospital network in France to integrate advanced telemetry features into its infusion systems. This collaboration is indicative of a growing trend towards digitalization in veterinary medicine, where real-time data monitoring can significantly improve patient outcomes. By enhancing its product capabilities through such partnerships, Medtronic is positioning itself as a frontrunner in the integration of technology within veterinary practices. In August Vetoquinol SA (FR) launched a new initiative aimed at sustainability, focusing on reducing the environmental impact of its manufacturing processes. This strategic action not only aligns with global trends towards sustainability but also resonates with the increasing consumer demand for environmentally responsible products. By prioritizing sustainability, Vetoquinol is likely to enhance its brand reputation and appeal to a broader customer base. As of November the competitive trends in the veterinary infusion-pumps market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and improving service delivery. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological innovation, enhanced patient care, and supply chain reliability. This shift suggests that companies that can effectively leverage these trends will likely secure a more favorable position in the market. ## Recent News & Developments In recent developments within the France Veterinary Infusion Pumps Market, there has been a notable increase in demand driven by the growing emphasis on animal healthcare and advanced treatment methods. Major players like MediLynx and Zoetis are focusing on enhancing their product offerings with innovative infusion technologies. Additionally, in October 2023, Smiths Medical announced a strategic partnership with Dechra Pharmaceuticals to enhance distribution channels in France, allowing for improved accessibility to veterinary infusion solutions. The competitive landscape is evolving, as companies such as Merit Medical Systems continue to invest in Research and Development to introduce more efficient infusion systems tailored for veterinary use. There have also been reports of increased market valuation for firms like Vygon and B. Braun Melsungen AG, indicating a robust growth trajectory that is expected to impact the sector positively. In the past two years, companies like Abbott Laboratories and Heska Corporation have expanded their presence in France, reinforcing their market positions through product diversification. The integration of advanced technologies and increased regulatory support in France is anticipated to further stimulate growth in the veterinary infusion segment, ensuring better outcomes for treatments in companion and farm animals alike. ## Report Scope | MARKET SIZE 2024 | 4.05(USD Million) | | --- | --- | | MARKET SIZE 2025 | 4.21(USD Million) | | MARKET SIZE 2035 | 6.28(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.07% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | B. Braun Melsungen AG (DE), Vetland Medical (US), Smiths Medical (US), Draegerwerk AG (DE), Medtronic (IE), Heska Corporation (US), Zoetis Inc. (US), Vetoquinol SA (FR) | | Segments Covered | Type, End-User | | Key Market Opportunities | Integration of advanced monitoring technologies enhances safety and efficacy in the veterinary infusion-pumps market. | | Key Market Dynamics | Rising demand for advanced veterinary infusion-pumps driven by regulatory changes and technological innovations in animal healthcare. | | Countries Covered | France | ## Frequently Asked Questions **Q: What was the market valuation of the veterinary infusion-pumps market in 2024?** A: The market valuation was $4.05 Million in 2024. **Q: What is the projected market valuation for the veterinary infusion-pumps market in 2035?** A: The projected valuation for 2035 is $6.28 Million. **Q: What is the expected CAGR for the veterinary infusion-pumps market during the forecast period 2025 - 2035?** A: The expected CAGR is 4.07% during the forecast period 2025 - 2035. **Q: Which types of infusion pumps are included in the market segments?** A: The market segments include Syringe Infusion Pumps and Large-Volume Infusion Pumps. **Q: What were the valuations for Syringe Infusion Pumps and Large-Volume Infusion Pumps in 2024?** A: Syringe Infusion Pumps were valued at $1.62 Million, while Large-Volume Infusion Pumps were valued at $2.43 Million in 2024. **Q: What are the key end-user segments in the veterinary infusion-pumps market?** A: Key end-user segments include Veterinary Hospitals, Veterinary Clinics, and Others. **Q: What were the valuations for Veterinary Hospitals and Veterinary Clinics in 2024?** A: Veterinary Hospitals were valued at $1.62 Million, and Veterinary Clinics were valued at $1.21 Million in 2024. **Q: Who are the key players in the veterinary infusion-pumps market?** A: Key players include B. Braun Melsungen AG, Vetland Medical, Smiths Medical, Draegerwerk AG, Medtronic, Heska Corporation, Zoetis Inc., and Vetoquinol SA. **Q: What is the anticipated growth trend for the veterinary infusion-pumps market in France?** A: The market appears to be on a growth trajectory, with a projected increase to $6.28 Million by 2035. **Q: How do the valuations of different end-user segments compare in 2024?** A: In 2024, Veterinary Hospitals were valued at $1.62 Million, Veterinary Clinics at $1.21 Million, and Others at $1.22 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/france-veterinary-infusion-pumps-market-54144*